Brief Client-Centered Motivational and Behavioral Intervention to Promote HPV Vaccination in a Hard-to-Reach Population: A Pilot Randomized Controlled Trial

Clinical Pediatrics

Volumn 55, Issue 9, 2016, Pages 851-859

  Joseph, Natalie Pierre ^a   Bernstein, Judith ^a   Pelton, Steve ^a   Belizaire, Myrdell ^a   Goff, Ginette ^a   Horanieh, Nour ^a   Freund, Karen M ^b  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

adolescent girls; Brief Negotiated Interview motivational intervention; Haitian mothers; hard to reach populations; HPV vaccination; minority and low income; pilot trial

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; ELECTRONIC MEDICAL RECORD; FEMALE; HUMAN; LOWEST INCOME GROUP; MOTIVATION; MOTIVATIONAL INTERVIEWING; OUTCOME ASSESSMENT; PATIENT ATTITUDE; PILOT STUDY; PRIMARY MEDICAL CARE; RANDOMIZED CONTROLLED TRIAL; VACCINATION; WART VIRUS; AFRICAN AMERICAN; ATTITUDE TO HEALTH; BEHAVIOR THERAPY; ETHNOLOGY; HAITI; HEALTH PROMOTION; MOTHER; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; STATISTICS AND NUMERICAL DATA;

ADOLESCENT; ADULT; AFRICAN AMERICANS; BEHAVIOR THERAPY; FEMALE; HAITI; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH PROMOTION; HUMANS; MOTHERS; MOTIVATIONAL INTERVIEWING; NUCLEAR FAMILY; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PILOT PROJECTS;

EID: 84979668796     PISSN: 00099228     EISSN: 19382707     Source Type: Journal    
DOI: 10.1177/0009922815616244     Document Type: Article

References (33)

1. Centers for Disease Control and Prevention. Human papillomavirus-associated cancers-United States, 2004-2008. MMWR Morb Mortal Wkly Rep. 2012; 61: 258.
2. Centers for Disease Control and Prevention. Cervical cancer rates by race and ethnicity. Atlanta, GA: Centers for Disease Control and Prevention; 2012. http://www.cdc.gov/cancer/cervical/statistics/race.htm. Accessed August 20, 2015.
3. Centers for Disease Control and Prevention. Quadrivalent human papillomavirus recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2007; 56: 1-24.
4. Jemal A, Simard EP, Dorell C, et al. Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels. J Natl Cancer Inst. 2013; 105: 175-201.
5. Centers for Disease Control and Prevention. Genital HPV infection: fact sheet. Atlanta, GA: Centers for Disease Control and Prevention; 2015. http://www.cdc.gov/std/HPV/STDFact-HPV.htm. Accessed March 31, 2015.
6. Markowitz LE, Hariri S, Lin C, et al. Reduction in human papillomavirus (HPV) prevalence among young women following HPV vaccine introduction in the United States, National Health and Nutrition Examination Surveys, 2003-2010. J Infect Dis. 2013; 208: 385-393.
7. Centers for Disease Control and Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010; 59: 626-629.
8. Petrosky E, Bocchini JA Jr, Hariri S,. Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the Advisory Committee on Immunization Practices. MMWR Morb Mortal Wkly Rep. 2015; 64: 300-304.
9. Markowitz LE, Dunne EF, Saraiya M, et al.Centers for Disease Control and Prevention. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2014; 63: 1-30.
10. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17-United States 2010. MMWR Morb Mortal Wkly Rep. 2011; 60: 1117-1123.
11. Kobetz E, Mendoza AD, Menard J, et al. One size does not fit all: differences in HPV knowledge between Haitian and African American women. Cancer Epidemiol Biomarkers Prev. 2010; 19: 366-370.
12. Elam-Evans LD, Yankey D, Jeyarajah J, et al.Immunization Services Division, National Center for Immunization and Respiratory Diseases; Centers for Disease Control and Prevention. National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years-United States, 2013. MMWR Morb Mortal Wkly Rep. 2014; 63: 625-633.
13. Joseph NP, Clark JA, Bauchner H, et al. Knowledge, attitudes, and beliefs regarding HPV vaccination: ethnic and cultural differences between African-American and Haitian immigrant women. Womens Health Issues. 2012; 22: e571-e579.
14. Joseph NP, Clark JA, Mercilus G, Wilbur M, Figaro J, Perkins R,. Racial and ethnic differences in HPV knowledge, attitudes, and vaccination rates among low-income African-American, Haitian, Latina, and Caucasian young adult women. J Pediatr Adolesc Gynecol. 2014; 27: 83-92.
15. American Academy of Family Physicians. Policies: immunizations. http://www.aafp.org/about/policies/all/immunizations.html. Accessed March 31, 2015.
16. American Cancer Society. American Cancer Society recommendations for human papillomavirus (HPV) vaccine use to prevent cervical cancer and pre-cancers; 2013. http://www.cancer.org/cancer/cancercauses/othercarcinogens/infectiousagents/hpv/acs-recommendations-for-hpv-vaccine-use. Accessed March 31, 2015.
17. National Cancer Institute. Accelerating HPV vaccination update: urgency for action to prevent cancer. [ a report to the President of United States from The President's Cancer Panel ]. Bethesda, MD: US Department of Health and Human Services; 2012-2013.
18. ACOG Committee on Adolescent Health Care. Committee Opinion number 467: human papillomavirus vaccination. Obstet Gynecol. 2010; 116: 800-803.
19. Stokley S, Jeyarajah J, Yankey D, et al. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and postlicensure vaccine safety monitoring, 2006-2014-United States. MMWR Morb Mortal Wkly Rep. 2014; 63: 620-624.
20. Akinsanya-Beysolow I, Advisory Committee on Immunization Practices (ACIP); ACIP Child/Adolescent Immunization Work Group. Advisory Committee on Immunization Practices recommended immunization schedules for persons aged 0 through 18 years-United States, 2014. MMWR Morb Mortal Wkly Rep. 2014; 63: 108-109.
21. Caskey R, Lindau ST, Alexander GC,. Knowledge and early adoption of the HPV vaccine among girls and young women: results of a national survey. J Adolesc Health. 2009; 45: 453.
22. The BNI ART Institute. Brief Negotiated Interview and Active Referral to Treatment. Boston University School of Public Health. http://www.bu.edu/bniart/. Accessed August 10, 2010.
23. Kahn JA, Lan D, Kahn RS,. Sociodemographic factors associated with high-risk human papillomavirus infection. Obstet Gynecol. 2007; 110: 87-95.
24. Dempsey AF, Zimet GD, Davis RL, Koutsky L,. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics. 2006; 117: 1486.
25. Zimet GD, Perkins SM, Sturm LA, et al. Predictors of STI vaccine acceptability among parents and their adolescent children. J Adolesc Health. 2005; 37: 179.
26. DiClemente CC,. Motivational interviewing and the stages of change. In: Miller WR, Rollnick S, eds. Motivational Interviewing: Preparing People to Change Addictive Behavior. New York, NY: The Guilford Press; 1991: 191-202.
27. Bernstein E, Bernstein J, Levenson S,. Project ASSERT: An ED-based intervention to increase access to primary care, preventive services and the substance abuse treatment system. Ann Emerg Med. 1997; 30: 181-189.
28. Hettema JE, Miller WR, Steele JM,. A meta-analysis of motivational interviewing techniques in the treatment of alcohol use disorders. Alcohol Clin Exp Res. 2004; 28: 74A.
29. Miller W, Rollnick S,. Motivational Interviewing: Preparing People to Change Addictive Behaviors. New York, NY: Guilford Press; 1991.
30. Bandura A,. Social Foundations of Thought and Action: A Social Cognitive Theory. Englewood Cliffs, NJ: Prentice Hall; 1986.
31. Bryant M, Farrin A, Christie D, Jebb SA, Cooper AR, Rudolf M,. Results of a feasibility randomized controlled trial (RCT) for WATCH IT: a program for obese children and adolescents. Clin Trials. 2011; 8: 755-764.
32. Centers for Disease Control and Prevention. National and state vaccination coverage among adolescents aged 13-17 years-United States 2012. MMWR Morb Mortal Wkly Rep. 2013; 62: 685-693.
33. Read TR, Hocking JS, Chen MY, Donovan B, Bradshaw CS, Fairley CK,. The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme. Sex Transm Infect. 2011; 87: 544-547.